Market Place
Sourcing Support
Lonza Announces First GMP Batch Completion at US Mammalian Facility
25 Nov 2024 //
INDPHARMAPOST
Swiss CDMO Lonza widens its ADC digs with 2028 expansion
13 Nov 2024 //
FIERCE PHARMA
Lonza’s Synaffix Partners with BigHat for ML-Designed ADC
05 Nov 2024 //
INDPHARMAPOST
Lonza Completes Acquisition of Biologics Site from Roche
01 Oct 2024 //
CONTRACT PHARMA
Acumen Pharma Extends Alzheimer’s Collaboration with Lonza
27 Sep 2024 //
CONTRACT PHARMA
Vertex adds CDMO Lonza to Casgevy production network
24 Sep 2024 //
FIERCE PHARMA
Lonza Launches Innovaform Accelerator CoE in France
19 Sep 2024 //
CONTRACT PHARMA
Lonza Completes Microbial Manufacturing Expansion in Visp
05 Sep 2024 //
CONTRACT PHARMA
Lonza Upgrades Clinical Manufacturing Services at Bend Site
07 Aug 2024 //
CONTRACT PHARMA
FDA Issues Form 483 to Lonza Group
15 Jul 2024 //
FDA
Lonza Group Welcomes New CEO
02 Jul 2024 //
CONTRACT PHARMA
Lonza to Enhance Governance with Updates to its Board Committee Structure
24 Jun 2024 //
PRESS RELEASE
Annexon`s neurological disease drug succeeds in late-stage study
05 Jun 2024 //
REUTERS
Q1 2024 Qualitative:Performance In Line with Expectations for Full-Year 2024
13 May 2024 //
PHARMIWEB
Lonza Announces Results of the 2024 Annual General Meeting
08 May 2024 //
PHARMIWEB
TriLink, Lonza In License Deal For CleanCap® mRNA Technology
30 Apr 2024 //
BUSINESSWIRE
Lonza launches AI-enabled Route Scouting Service to accelerate molecule devp
29 Apr 2024 //
INDINPHARMAPOST
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon
17 Apr 2024 //
PRESS RELEASE
NeuroSense, Lonza Partner On Exosome Biomarkers, Neurodegeneration
09 Apr 2024 //
PR NEWSWIRE
Lonza, NeuroSense Enter Alliance for ALS Candidate
09 Apr 2024 //
CONTRACTPHARMA
Lonza, Acumen Pharmaceuticals Ink Alzheimer’s Alliance
04 Apr 2024 //
GLOBENEWSWIRE
Lonza names Siegfried Holding boss as new CEO
02 Apr 2024 //
REUTERS
Lonza Expands Spray-Drying Services for Protein-Based Inhaled Therapies
27 Mar 2024 //
CONTRACT PHARMA
Lonza Signs Agreement to Acquire Large-Scale Biologics from Roche
20 Mar 2024 //
PRESS RELEASE
Lonza to buy large biologics site from Roche in US for $1.2 bln
20 Mar 2024 //
REUTERS
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18
05 Mar 2024 //
BUSINESSWIRE
Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth
26 Jan 2024 //
PRESS RELEASE
Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza
26 Jan 2024 //
PRESS RELEASE
Lonza chairman to step down, drugmaker confirms targets, shares soar
26 Jan 2024 //
REUTERS
Lonza closes plant in China but has a turnaround quarter
26 Jan 2024 //
FIERCE PHARMA
Lonza telegraphs hefty layoff round at California plant
17 Jan 2024 //
FIERCE PHARMA
NightHawk becomes pure-play CDMO; Lonza to make liver cancer drug
14 Dec 2023 //
ENDPTS
Medivir have agreed with Lonza to manufacture a fostrox GMP campaign
13 Dec 2023 //
PR NEWSWIRE
Exclusive: Manufacturer Lonza says it will not fill obesity drug syringes
17 Nov 2023 //
REUTERS
Lonza’s forecast for gene therapies points to uncertainty about sector`s future
19 Oct 2023 //
ENDPTS
Vaxcyte & Lonza Expand Collaboration for Global Commercial Manufacturing of PCVs
16 Oct 2023 //
GLOBENEWSWIRE
Lonza to add new filling line, 100 jobs at future Swiss site
16 Oct 2023 //
FIERCE PHARMA
Lonza expands antibody-drug conjugate pact, plots 180 hires
05 Oct 2023 //
FIERCE PHARMA
Bluebird tweaks partnership with Lonza to boost Zynteglo
27 Sep 2023 //
ENDPTS
Moderna to cut mRNA drug substance production at Lonza facility
19 Sep 2023 //
REUTERS
More leadership instability at Lonza as CEO Ruffieux steps down
18 Sep 2023 //
FIERCE PHARMA
Catalent poaches Lonza`s David McErlane to head up biologics
18 Sep 2023 //
FIERCE PHARMA
Lonza, Vertex Break Ground for Cell Therapy Mfg. Facility
31 Aug 2023 //
CONTRACT PHARMA
Lonza cites biotech funding slowdown as it lowers sales outlook for the year
21 Jul 2023 //
ENDPTS
Lonza launches new cell culture media system TheraPRO
18 Jul 2023 //
INDIAN PHARMA POST
Vertex and Lonza team up on new cell therapy production plant
26 Jun 2023 //
FIERCE BIOTECH
Lonza Acquires Synaffix for €100M
01 Jun 2023 //
CONTRACT PHARMA
Lonza launches TheraPEAK T-VIVO cell culture medium
24 May 2023 //
INDIAN PHARMA POST
Lonza Prices EUR 500 Million Straight Bond with a 3.875% Coupon
16 May 2023 //
PRESS RELEASE
Q1 Qualitative Update: Business Performance In Line With Full-Year Trajectory
10 May 2023 //
PRESS RELEASE
Lonza Announces Results of the 2023 Annual General Meeting
05 May 2023 //
PRESS RELEASE
Boehringer and Lonza question the future of FDA`s regulation of AI in Mfg
02 May 2023 //
ENDPTS
Lonza Increases Straight Bond by CHF 150 Million
20 Apr 2023 //
PHARMIWEB
Lonza, ABL Bio Partner to Develop and Manufacture Bispecific Antibody Product
04 Apr 2023 //
CONTRACT PHARMA
Lonza Launches Share Buyback Program of up to CHF 2 Billion
31 Mar 2023 //
PRESS RELEASE
Lonza Completes Clinical, Commercial Drug Product Manufacturing Line in Visp
29 Mar 2023 //
CONTRACT PHARMA
Lonza Publishes Invitation to the 2023 Annual General Meeting
27 Mar 2023 //
PRESS RELEASE
Simris Alg AB, Lonza Partner to Promote ADC Payload Technology
10 Mar 2023 //
CONTRACT PHARMA
Lonza Upgrades Powder Characterization Capabilities at Tampa Site
08 Mar 2023 //
CONTRACT PHARMA
Lonza Completes Expansion of Conjugation Facility in Visp
16 Feb 2023 //
CONTRACT PHARMA
